Zoledronic acid delays the onset of skeletal-related events and progression of skeletal disease in patients with advanced renal cell carcinoma.

v1

Type:Journal Article

0 views

[![NobleID](https://www.nobleid.org/api/badge/C8722BAF.svg?ark=w1%2F20260515%2FC8722BAF)](https://nobleid.org/work/w1/20260515/C8722BAF)

ARK Inflections

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors